Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples